 NEW YORK, Jan. 05, 2022 GLOBE NEWSWIRE -- Indaptus Therapeutics, Inc. Nasdaq: INDP Indaptus or the Company, today announced that Jeffrey Meckler, Chief Executive Officer, will participate in a pre-recorded presentation at the H.C. Wainwright BioConnect 2022 Virtual Conference made available on Monday, January 10, 2022 at 7:00 a.m. ET. 